3DMed raises RMB670M

Cancer company 3D Medicines Corp. (Shanghai, China) raised RMB670 million ($101.1 million) on Nov. 23 in a round led by China Reform Holdings Corp. Ltd. ChinaEquity Group and undisclosed other investors also participated...